DIMERIX LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.58 AUD | -4.13% |
|
+7.41% | +182.93% |
| May. 29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
| May. 27 | Dimerix Signs License Deal for Kidney Disease Medication in the Middle East | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DIMERIX LIMITED | Other Biotechnology & Medical Research | -4.13% | +7.41% | +182.93% | +917.54% | +653.25% | 223M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- DXB Stock
- Charts Dimerix Limited
- Comparison Chart
